Natural product therapy for pulmonary arterial hypertension: 5,7-Dihydroxy-6-geranyl flavanone (DGF), isolated from Amorpha Fructicosa, inhibits the development of pulmonary arterial hypertension via down regulation of Notch3 and its target gene Hes-5, 26/June/2017, 10.36 pm

Natural product therapy for pulmonary arterial hypertension: 5,7-Dihydroxy-6-geranyl flavanone (DGF), isolated from Amorpha Fructicosa, inhibits the development of pulmonary arterial hypertension via down regulation of Notch3 and its target gene Hes-5, 26/June/2017, 10.36 pm

Natural product therapy for pulmonary arterial hypertension: 5,7-Dihydroxy-6-geranyl flavanone (DGF), isolated from Amorpha Fructicosa, inhibits the development of pulmonary arterial hypertension via down regulation of Notch3 and its target gene Hes-5, 26/June/2017, 10.36 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say: 

A study from the University of California, La Jolla, California, USA shows that Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of the journalNature Medicine”[the number 1 journal in General Medicine with an I.F of 28.054] by Prof. Thistlethwaite PA, Li X and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product therapy for pulmonary arterial hypertension:5,7-Dihydroxy-6-geranyl flavanone (DGF), isolated from Amorpha Fructicosa, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes5


Significance of the study:  

5,7-Dihydroxy-6-geranyl flavanone (DGF), by increasing the expression of its target gene, it may decrease the expression of Notch3 and its target gene Hes-5 (Fig.1).  Thus, pharmacological formulations encompassing “5,7-Dihydroxy-6-geranyl flavanone (DGF) or its analog, either alone or in combination with other drugs” may be used to treat pulmonary arterial hypertension.[easy_payment currency=”USD”]

Figure 1. Mechanistic insights into how 5,7-Dihydroxy-6-geranyl flavanone (DGF) inhibits the development of pulmonary hypertension.


Details of the research findings:

Idea formulated by : Dr. L Boominathan PhD

Amount: $100#

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How 5,7-Dihydroxy-6-geranyl flavanone (DGF) inhibits Notch-3 expression

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References: 

Web: http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan, L.,  Natural product therapy for pulmonary arterial hypertension:5,7-Dihydroxy-6-geranyl flavanone (DGF), isolated from Amorpha Fructicosa, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes-5, 26/June/2017, 10.35 pm Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, drop us a line at info@genomediscovery.org